PUBH6007: Program Logic & Plan for Overweight/Obesity Adults

This assignment presents a comprehensive program design for the management of overweight and obesity in adults, structured around a prioritized need. It includes a program logic diagram detailing resources, activities, outputs, and short-term, intermediate, and long-term impacts. The program plan outlines the overarching goal of reducing cardiovascular risk factors, specific objectives related to weight loss and health improvement, strategies for achieving these objectives, and process indicators to monitor progress. Data collection methods for these indicators are described, alongside an evaluation plan encompassing both impact and outcome assessments. Ethical considerations, potential risks, and management strategies are addressed, as well as resource requirements and a project budget. The assignment also lists relevant references to support the program design and evaluation process. Desklib offers a wealth of similar solved assignments and past papers to aid students in their studies.

Logic diagram for a program based on prioritized need
Patient
Encounter
(See Box 1)
Measure weight,
height; calculate
BMI
(See Box 2)
Yes
BMI ≥25
Assess and treat risk
factors for CVD and
obesity-related
comorbidities
(See Box 4)
Assess weight and
lifestyle histories
(See Box 5)
Advise to
avoid weight gain;
address and treat
other risk factors
(See Box 7)
No, insufficient risk
No, not yet ready
No
BMI 18.5-24.9
Measure weight
and calculate BMI
annually or more
frequently
(See Box 17) Yes
Evaluation
Treatment
BMI 25-29.9 (overweight)
or 30-34.9 (class I obese)
or 35-39.9 (class II obese)
or ≥40 (class III obese)
(See Box 3)
Assess need to
lose weight:
BMI ≥30 or BMI 25-29.9
with risk factor(s)
(See Box 6)
Assess readiness to
make lifestyle changes
to achieve weight loss
(See Box 8)
Yes, ready
Follow-up and
weight loss
maintenance
(See Box 15)
Determine weight loss
and health goals and
intervention strategies
(See Box 9)
Comprehensive lifestyle
intervention alone or
with adjunctive therapies
(BMI ≥30 or ≥27 with
comorbidity)
(See Box 10)†
High-intensity
comprehensive
lifestyle
intervention
(See Box 11a)
Alternative delivery
of lifestyle
intervention
(See Box 11b)
BMI ≥30 or BMI ≥27 with
comorbidity—option for adding
pharmacotherapy as an adjunct to
comprehensive lifestyle
intervention
(See Box 12)†
BMI ≥40 or BMI ≥35 with comorbidity.
Offer referral to an experienced
bariatric surgeon for consultation and
evaluation as an adjunct to
comprehensive lifestyle intervention
(See Box 13)
Yes
Yes
Continue intensive
medical management of
CVD risk factors and
obesity-related
conditions; weight
management options
(See Box 19)
Intensive behavioral
treatment (See Box 10);
reassess and address
medical or other
contributory factors;
consider adding or
reevaluating obesity
pharmacotherapy
(See Box 12), and/or
refer to an experienced
bariatric surgeon
(See Box 13)
No
No
Yes, ready
Weight loss ≥5%
and sufficient improvement
in health targets
(See Box 14)
Weight
loss ≥5% and sufficient
improvement
in health targets
(See Box 18)

Management of overweight and obesity in
adults.
1. Overweight refers to an increase in body weight relative to height
compared to certain criteria for acceptable or required weight.
Obesity is an excessive amount of fat in a body associated with lean body
mass.
3. Overweight is a body mass index of 25 to 29.9 kg / m2.
4. Obesity was defined as the total fat excess recorded by BMI > 30 kg / m2.
5. The prevalence of obesity and overweight increased somewhat from 37.8%
for men to 39.4% & from 23.6% for women to 24.7%.
6. However, during the same period, the prevalence of the obesity increased
from 9.4% in men to 19.9%, and in women from 20.1% to 25.9% (Heber, 2013).

PART 1: Resources
Recommend other
resources (for example,
self-help and support
groups)
Liaison with
community projects
(e.g., work, school,
church)
National Audit Office
data
Weight Control
Information Network
Information sheets
and brochures
Audiovisual and
educational materials

Activities

Outputs
Includes weight loss or obesity (desired results)
and acceptable measures include weight,
relative weight, total obesity measurements, or
changes in any of these measures.
After the intervention, including weight
maintenance; and metabolic consequences
(glucose tolerance, blood pressure,
dyslipidemia)
Interventions can be applied to patients
seeking care in primary care settings, and
clinicians often provide interventions.
If a high-intensity inclusive lifestyle
intervention plan is not feasible, another
option is to refer to a nutrition expert for
the dietary counseling.

Short term impacts
A. Losing weight can reduce many of health risks connected
with obesity, also including insulin resistance, diabetes,
sleep apnea, high blood pressure, dyslipidemia,
hypoxemia, and hypercapnia, moreover osteoarthritis.
B. The Potential adverse effect of the weight loss includes
the greater threat of gallstone formation furthermore
cholecystitis, the excessive losses of lean body mass,
electrolyte problems or water, mild liver dysfunction, as
well as elevated uric acid level.
C. Minor consequences can also occur, for example diarrhea,
hair loss, constipation or cold intolerance.
D. Short-range adverse reactions are not sufficient to
prohibit weight loss and will not exceed their short-term
benefits.

Intermediate impacts

Long term impacts

Overarching goal of the program

Objectives
1. The primary goal of the program is to provide weight loss health benefits
for overweight and obese adults in reducing cardiovascular risk elements
as well as events, morbidity or mortality.
2. The main goal of the program is to determine whether the risk reduction
varies with pre-weight hazard elements, age, overweight, and gender,
waist and race circumference.
3. Another ambition is to assess the extent to which weight loss is linked
with a detectable improvement in threat elements/events, whether there
are the proofs of greater improvement in weight loss or the advantages of
long-term weight loss (Ivezaj, White &Grilo, 2016).
4. These are the significant topic that provides evidence to support the
judgment of the relative advantages of weight loss or can explain this
advantage to a patient considering weight losses programs.

Strategies